Award
NIH Reporter #1R43IP001282-01
Low-cost and high efficiency DNA-based Reverse Genetics Platforms for manufacturing RNA virus products.
Recipient
Domestic for-profit organization based in Athens, Ohio
Award Amount
$279,270.00
Ceiling
$279,270.00
Awarded
September 12, 2025
Identifier
1R43IP001282-01
Award for developing efficient DNA-based reverse genetics platforms for RNA virus manufacturing, funded by NIH with $279,270.
Description
The project aims to develop scalable, low-cost, and efficient DNA-based reverse genetics systems for RNA virus production using alphaviruses and Influenza virus as prototypes. It involves developing DNA-only systems involving direct use of DNA vectors.